Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions
Moon, D H, Lee, J-M, Noonan, A M, Annunziata, C M, Minasian, L, Houston, N, Hays, J L, Kohn, E CVolume:
109
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2013.389
Date:
August, 2013
File:
PDF, 294 KB
english, 2013